(Q42445979)

31 October 2017

title

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor (English)

1 reference

31 October 2017

0 references

0 references

0 references

R S Landsman

1

1 reference

31 October 2017

T H Burkey

2

1 reference

31 October 2017

P Consroe

3

1 reference

31 October 2017

W R Roeske

4

1 reference

31 October 2017

H I Yamamura

5

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

European Journal of Pharmacology

31 October 2017

published in

1 reference

31 October 2017

volume

334

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

R1-2

1 reference

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901160-6

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901160-6

Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901160-6

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901160-6

10.1016/S0014-2999(97)01160-6

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference